Notes
What I think about while working.
At least one article a month, no editorial calendar. Published here first, shared on LinkedIn after.
A new model is out. Do you really need to switch?
Changing the model behind a production agent costs far more than one line of code. Before migrating, I look at three things: cost, real improvement, and whether anything is forcing us.
ReadOnly 1% of trials involve AI. Look at who runs them
The number people will share is 1%. The part worth reading is who signs those studies: hospitals and universities, not industry.
ReadEmulatRx: five agents designing a clinical trial
A multi-agent system that designs trials from real-world data. How this architecture will reach clinical research: task by task, not as one product.
ReadRolling out AI in an SME: provider, plan, licence
Three decisions, in this order. Most of the complexity in an AI rollout is in the pricing pages, not in the decision itself.
Read